Search company, investor...

Stage

Grant | Alive

Total Raised

$150K

Last Raised

$150K | 14 yrs ago

About Insera Therapeutics

Insera Therapeutics is a company that received a SBIR Phase I grant for a project entitled: Technology development and pre-clinical testing of a novel minimally invasive catheter-based blood clot-retrieval and clot-filtering device. Their project aims to develop the industry's first catheter-based stroke treatment device that serves both as a blood clot-retrieval as well as a clot-filtering device. Stroke is a major economic burden on the tax payer costing $65.5 billion/year. The mean lifetime healthcare cost for a stroke patient is $140,048. The first step in the treatment of acute stroke is the removal of the blood clot to restore vital blood supply to the brain. However, existing catheter-based therapies have only shown modest success in removing clots and are effective in less than two-thirds of stroke patients. In addition, these therapies can release debris into the blood stream causing further strokes. The research objective of this project is to perform pre-clinical testing of a more effective clot-retrieval device and a clot-filtering device that can make existing stroke therapies safer. The broader impacts of this research are far-reaching as the global stroke burden is staggering. Each year 780,000 strokes occur in the US and nearly 20.5 million strokes occur worldwide. This project is projected to yield important outcomes. First, the efficacy of this clot-retrieval device in removing blood clots will be confirmed. Second, the efficacy of this clot-filtering device will be confirmed in preventing release of debris during catheter-based stroke treatments thereby making these procedures safer. This public-private partnership is expected to have an important positive impact on the community by saving lives, creating jobs, and decreasing the economic burden of stroke on the tax payer.

Headquarters Location

1560 Arcola Avenue

Sacramento, California, 95835,

United States

916-849-0945

Loading...

Loading...

Insera Therapeutics Patents

Insera Therapeutics has filed 75 patents.

The 3 most popular patent topics include:

  • rare diseases
  • vascular diseases
  • inflammations
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/23/2018

4/12/2022

Vascular diseases, Stroke, Hematology, Rare diseases, Inflammations

Grant

Application Date

2/23/2018

Grant Date

4/12/2022

Title

Related Topics

Vascular diseases, Stroke, Hematology, Rare diseases, Inflammations

Status

Grant

Latest Insera Therapeutics News

Ischemic Stroke Aspiration Systems Market | Medtronic, Penumbra Inc., Insera Therapeutics, Imperative Care Inc. | By 2032

Apr 18, 2023

will be worth US$ 1531.6 million. The market is expanding quickly as a result of rising hospital and clinic demand. According to FMI Analysts, the global market for ischemic stroke aspiration systems is anticipated to reach US$ 595.93 million in 2022 and grow at a CAGR of 9.9% from 2022 to 2032. With 1000+ market research reports and 1 billion+ data points, Future Market Insights (FMI) serves each and every requirement of the clients operating in the global healthcare, pharmaceuticals, and medical device industries. FMI deploys digital intelligence solutions to offercompelling insights to report buyersthat help them in overcoming market challenges, especially at the time of a crisis. Our dedicated team of professionals performs an extensive survey for gathering accurate information associated with the market. To Get the Sample Copy of Report visit @ FMI, in its upcoming business report, elaborates the historical and current scenario of the global Ischemic Stroke Aspiration Systems market in terms of production, consumption, volume, and value. The report scrutinizes the market into various segments, regions and players on the basis of demand pattern and growth prospects. Crucial information and forecast statistics covered in the Ischemic Stroke Aspiration Systems market report will arm both existing and emerging market players with necessary insights to craft long-term strategies as well as maintain business continuity during a crisis such as the ongoing COVID-19 pandemic. COVID-19 Impact Analysis on Ischemic Stroke Aspiration Systems Market The recent outbreak of the COVID-19 has turned the spotlight on the healthcare industry, and subsequently impacted the Ischemic Stroke Aspiration Systems market. Severe shortages of critical medical supplies and a rapid rise in number of COVID-19 cases have resulted into a revolution rather than evolution in the healthcare ecosystems. Consequently, the impact is noticeable in the Ischemic Stroke Aspiration Systems market. Ask An Analyst@  https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-9662 Following government’s measures, particularly social distancing norms and stay-at-home orders, doctors are delaying or postponing elective surgeries unless critical to prevent the spread of the virus to individuals with comorbidities or chronic conditions. Additionally, movement restrictions and supply chain disruptions have created a logistical nightmare for market players, leading to severe product shortages in the global marketplace. The FMI’s report includes an interesting chapter on preliminary impact of the COVID-19 on the Ischemic Stroke Aspiration Systems market. This allows both leading and emerging market players to understand the market scenario during a crisis and aids them in making sound decisions to gain a distinct competitive edge. Why Choose Future Market Insights Serving domestic and international clients 24/7 Prompt and efficient customer service Data collected from reliable primary and secondary sources Highly trained and experienced team of research analysts Seamless delivery of tailor-made market research reports Ischemic Stroke Aspiration Systems Market: Segmentation Valuable information covered in the FMI’s Ischemic Stroke Aspiration Systems market report has been segregated into key segments and sub-segments. By End user Which end user remains the top revenue contributor in different regional markets? At what rate has the global Ischemic Stroke Aspiration Systems market been expanding during the forecast period? How will the global Ischemic Stroke Aspiration Systems market look like by the end of the forecast period? What innovative strategies are adopted by Ischemic Stroke Aspiration Systems market players to stay ahead of the pack? What are the restraints affecting the growth of the global Ischemic Stroke Aspiration Systems market? Key Offerings of the Report Growth Drivers and Opportunities: Comprehensive analysis on growth-driving factors and opportunities for market players in different regional markets Recent Trends and Forecasts: Detailed assessment on the latest trends, technological developments, and forecasts for a 5-year or 10-year period. Segmental Analysis: Extensive analysis on each segment and factors differentiating the role of these segments in market revenue forecasts and growth rate analysis Regional Market Forecast: Thorough analysis of each regional market to arm stakeholders with necessary information to take critical decisions Competitive Landscape: All-inclusive insights on both leading and emerging players vying for a slice of the Ischemic Stroke Aspiration Systems market About Future Market Insights (FMI) Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years. Contact Us:

Insera Therapeutics Frequently Asked Questions (FAQ)

  • Where is Insera Therapeutics's headquarters?

    Insera Therapeutics's headquarters is located at 1560 Arcola Avenue, Sacramento.

  • What is Insera Therapeutics's latest funding round?

    Insera Therapeutics's latest funding round is Grant.

  • How much did Insera Therapeutics raise?

    Insera Therapeutics raised a total of $150K.

  • Who are the investors of Insera Therapeutics?

    Investors of Insera Therapeutics include National Science Foundation.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.